A. Leigh Corbett

Staff Reporter

Email: corbett@ocbj.com
Phone: 949-833-8373 Extension: 254

Recent Stories

Midday Stock Roundup

FivePoint up 31% this week (keep reading)

Tease photo

Urovant Gets Japan Investor Boost

$300M Loan; FDA Progress for 2020

Urovant Sciences Ltd. (Nasdaq: UROV), which is developing medications to treat urologic issues, is starting the year with a new main investor from Japan, a $300 million loan, and progress in getting its core drug, vibegron, to market in the U.S.

Midday Stock Roundup

Axonics Modulation Technologies Inc. leaps 25% (keep reading)

Tease photo

AbbVie Names Strom to Head Allergan Unit

“The future has never been brighter"

Tease photo

Annette Walker’s Billion Dollar Plan to Fight Cancer

HEALTHCARE: Irvine opening expected in ’21

Cancer treatment plans went big in Orange County in 2019—witness Mission Hospital’s November unveiling of its new Judi and Bill Leonard Institute for Cancer Prevention, Treatment and Wellness in Mission Viejo, and the $120 million in funding now raised by Irvine’s Laboratory for Advanced Medicine, a 5-year-old firm that uses artificial intelligence to identify early stages of specific cancers.

CathWorks Gets Japanese Approval

First Such Artery Imaging Device for Japan

Aliso Viejo-based CathWorks, a medical device maker that provides 3D imaging of the coronary artery branch, announced in December the approval of its FFRangio system by Japan’s Ministry of Health, Labour and Welfare.

Axonics Adds to Patent Count

Still Faces Medtronic Infringement Charges

Irvine-based device maker Axonics Modulation Technologies Inc. (Nasdaq: AXNX) won nine new patents pertaining to its main electrostimulation product, at the same time it’s being sued by Medtronic PLC for patent infringement.

Midday Stock Roundup

Ducommun dives; Endologix leaps (keep reading)

Tease photo

Midday Stock Roundup

Willdan Group midday trading volume was well below average

Tease photo

2020 Preview: HEALTHCARE

Cancer Treatment, Legal Issues at Forefront

2018 was the Year of the IPO for OC’s healthcare scene, with a quartet of drugmakers, device makers and medical aesthetics firms joining the ranks of the publicly traded.

More stories >>